🏷️ À propos: Please note: This application is intended for use by healthcare professionals as a decision support tool. It is not designed for use by patients and does not replace the advice of a doctor.
Oui. ONCOassist est très sûr à utiliser. Ceci est basé sur notre analyse NLP (Traitement du langage naturel) de plus de 7 avis d'utilisateurs provenant de l'Appstore et la note cumulative de l"Aappstore de 4.7/5 . Score de sécurité Justuseapp pour ONCOassist Est 87.5/100.
Oui. ONCOassist est une application totalement légitime. Cette conclusion a été obtenue en passant 7 ONCOassist avis d'utilisateurs via notre processus d'apprentissage automatique NLP pour déterminer si les utilisateurs croient que l'application est légitime ou non. Sur cette base, Justuseapp Score de légitimité pour ONCOassist Est 100/100..
ONCOassist fonctionne la plupart du temps. Si cela ne fonctionne pas pour vous, nous vous recommandons de faire preuve de patience et de réessayer plus tard ou Contacter le support.
Oncology professionals no longer waste time searching through the internet for safe validated information to aid them with their decision making, all of the tools and information they need is available within ONCOassist and is available without the need for internet access.
• A suite of prognostic tools which can help in prognostication, risk stratification and deciding on eligibility for specific treatments or clinical trials including the Motzer criteria for renal cancer and the IPI score for diffuse large B cell lymphoma.
ONCOassist™ provides oncology professionals with a suite of easy to use decision support tools to manage patients care.
• Adjuvant decision support tools for breast cancer, lung cancer, colon cancer and a GIST tool.
Adjuvant decision support tools contain patient-friendly information to allow for a more collaborative decision-making process.
• AJCC 8th and 7th edition staging tool that provides easy access to the full library of AJCC criteria for every malignancy.
Please note: This application is intended for use by healthcare professionals as a decision support tool.
ONCOassist will be updated regularly with new prognostic tools and calculators.
ONCOassist is regulated by the Irish Health Products Regulatory Authority and is CE marked for conformance as a medical device.
• Common toxicity criteria for adverse events version 5.0 and 4.0 in an easy to use and interactive format.
It is not designed for use by patients and does not replace the advice of a doctor.
ONCOassist promotes the use of evidence-based medicine.
It is also the only CE approved oncology app on the market.
We will listen to your feedback and update accordingly.
